Dyno Therapeutics

dynotx.com

Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy, utilizing machine learning and quantitative high-throughput in vivo experimentation to design novel gene vectors. The company focuses on developing cell-targeting capsid proteins from adeno-associated virus (AAV), which is the most widely-used vector for gene therapies. By creating proprietary AAV vectors and collaborating with licensing partners, Dyno aims to enhance the efficacy of gene therapies, enabling treatments for a broader range of diseases and patients. With a strong team of molecular biologists, protein engineers, and AI experts, Dyno is positioned to transform the gene therapy landscape and improve patient outcomes.